EGFR and lung carcinoma: Lipid rafts have been implicated in a variety of cellular processes, including signaling transduction of RTK 46, AXL 33 and c-MET 47 RTKs, by contributing to the pathophysiology of lung cancer and the acquired resistance to EGFR TKI.